Abasi Ene-Obong is a Nigerian techpreneur. He is the founder and CEO of 54gene, a health technology company accelerating the state of healthcare through large-scale discovery and translational research, advanced molecular diagnostics, and clinical programs for the benefit of Africans and the global population.
Scholarly enriched, he holds a Ph.D. in Cancer Biology from the University of London, a Masters in human molecular genetics from Imperial College London, and a Masters in Business Management from Claremont Colleges, California. Ene-Obong has worked as a cancer researcher and published a seminar paper on pancreatic cancer immunology, Gastroenterology Journal.
Appropriately armed with extensive experience in the United States, United Kingdom and Nigerian healthcare industries, Ene-Obong has been able to ace his health-centric company to the fore of global repute.
Founded in 2019, 54gene made the Time Magazine list of 12 innovations that would change healthcare in the 2020s. 54gene also made the Fast Company list of the world’s ‘Most Innovative Companies’ in 2020. The company was also awarded the best health technology solution by AppsAfrica and Ene-Obong was listed as one of 30 most innovative entrepreneurs on the African continent in 2019 by Quartz Africa.
Revered as a Nigerian hero for his tremendous contributions to the fight against COVID-19, he was also included in Fortune’s 40 under 40 most influential people in healthcare for the year 2020.
